{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T20:40:12Z","timestamp":1768941612327,"version":"3.49.0"},"reference-count":94,"publisher":"e-Century Publishing Corporation","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Cancer Res"],"DOI":"10.62347\/ucjb2516","type":"journal-article","created":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T06:38:27Z","timestamp":1760078307000},"page":"4092-4107","source":"Crossref","is-referenced-by-count":0,"title":["Exercise pre-conditioning prevents vascular toxicity caused by infusion of 5-fluorouracil in male rats"],"prefix":"10.62347","volume":"15","author":[{"given":"Stephen T","family":"Hammond","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"48694","published-online":{"date-parts":[[2025]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/179663a0","article-title":"Fluorinated pyrimidines, a new class of tumour-inhibitory compounds","volume":"179","author":"Heidelberger","year":"1957","unstructured":"Heidelberger C, Chaudhuri NK, Danneberg P, Mooren D, Griesbach L, Duschinsky R, Schnitzer RJ, Pleven E and Scheiner J. Fluorinated pyrimidines, a new class of tumour-inhibitory compounds. Nature 1957; 179: 663-666.","journal-title":"Nature"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Dyhl-Polk A, Schou M, Vistisen KK, Sillesen AS, Serup-Hansen E, Faber J, Klausen TW, Bojesen SE, Vaage-Nilsen M and Nielsen DL. Myocardial ischemia induced by 5-fluorouracil: a prospective electrocardiographic and cardiac biomarker study. Oncologist 2021; 26: e403-e413.","DOI":"10.1002\/onco.13536"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1002\/j.1875-9114.1997.tb03748.x","article-title":"Symptomatic cardiotoxicity associated with 5-fluorouracil","volume":"17","author":"Meyer","year":"1997","unstructured":"Meyer CC, Calis KA, Burke LB, Walawander CA and Grasela TH. Symptomatic cardiotoxicity associated with 5-fluorouracil. Pharmacotherapy 1997; 17: 729-736.","journal-title":"Pharmacotherapy"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1200\/JCO.1989.7.4.509","article-title":"Continuous ambulatory ECG monitoring during fluorouracil therapy: a prospective study","volume":"7","author":"Rezkalla","year":"1989","unstructured":"Rezkalla S, Kloner RA, Ensley J, al-Sarraf M, Revels S, Olivenstein A, Bhasin S, Kerpel-Fronious S and Turi ZG. Continuous ambulatory ECG monitoring during fluorouracil therapy: a prospective study. J Clin Oncol 1989; 7: 509-514.","journal-title":"J Clin Oncol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1758835918780140","DOI":"10.1177\/1758835918780140","article-title":"5-fluorouracil and cardiotoxicity: a review","volume":"10","author":"Sara","year":"2018","unstructured":"Sara JD, Kaur J, Khodadadi R, Rehman M, Lobo R, Chakrabarti S, Herrmann J, Lerman A and Grothey A. 5-fluorouracil and cardiotoxicity: a review. Ther Adv Med Oncol 2018; 10: 1758835918780140.","journal-title":"Ther Adv Med Oncol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1159\/000072334","article-title":"A planned surveillance study with 102 patients","volume":"65","author":"Wacker","year":"2003","unstructured":"Wacker A, Lersch C, Scherpinski U, Reindl L and Seyfarth M. High incidence of angina pectoris in patients treated with 5-fluorouracil. A planned surveillance study with 102 patients. Oncology 2003; 65: 108-112.","journal-title":"Oncology"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.jaccao.2020.12.005","article-title":"The incidence, risk factors, and outcomes with 5-fluorouracil-associated coronary vasospasm","volume":"3","author":"Zafar","year":"2021","unstructured":"Zafar A, Drobni ZD, Mosarla R, Alvi RM, Lei M, Lou UY, Raghu VK, Murphy SP, Jones-O’Connor M, Hartmann S, Gilman HK, Weekes CD, Clark JR, Clark J, Blaszkowsky L, Tavares E and Neilan TG. The incidence, risk factors, and outcomes with 5-fluorouracil-associated coronary vasospasm. JACC CardioOncol 2021; 3: 101-109.","journal-title":"JACC CardioOncol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1159\/000339573","article-title":"Acute reversible heart failure caused by coronary vasoconstriction due to continuous 5-fluorouracil combination chemotherapy","volume":"5","author":"Dechant","year":"2012","unstructured":"Dechant C, Baur M, Bock R, Czejka M, Podczeck-Schweighofer A, Dittrich C and Christ G. Acute reversible heart failure caused by coronary vasoconstriction due to continuous 5-fluorouracil combination chemotherapy. Case Rep Oncol 2012; 5: 296-301.","journal-title":"Case Rep Oncol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1080\/0284186X.2019.1711164","article-title":"Incidence and risk markers of 5-fluorouracil and capecitabine cardiotoxicity in patients with colorectal cancer","volume":"59","author":"Dyhl-Polk","year":"2020","unstructured":"Dyhl-Polk A, Vaage-Nilsen M, Schou M, Vistisen KK, Lund CM, Kumler T, Appel JM and Nielsen DL. Incidence and risk markers of 5-fluorouracil and capecitabine cardiotoxicity in patients with colorectal cancer. Acta Oncol 2020; 59: 475-483.","journal-title":"Acta Oncol"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Lestuzzi C, Stolfo D, De Paoli A, Banzato A, Buonadonna A, Bidoli E, Tartuferi L, Viel E, De Angelis G, Lonardi S, Innocente R, Berretta M, Bergamo F, Guglielmi A, Sinagra G and Herrmann J. Cardiotoxicity from capecitabine chemotherapy: prospective study of incidence at rest and during physical exercise. Oncologist 2022; 27: e158-e167.","DOI":"10.1093\/oncolo\/oyab035"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1016\/j.ctrv.2013.03.005","article-title":"Cardiotoxicity in cancer patients treated with 5-fluorouracil or capecitabine: a systematic review of incidence, manifestations and predisposing factors","volume":"39","author":"Polk","year":"2013","unstructured":"Polk A, Vaage-Nilsen M, Vistisen K and Nielsen DL. Cardiotoxicity in cancer patients treated with 5-fluorouracil or capecitabine: a systematic review of incidence, manifestations and predisposing factors. Cancer Treat Rev 2013; 39: 974-984.","journal-title":"Cancer Treat Rev"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1093\/oxfordjournals.eurheartj.a059919","article-title":"Coronary artery spasm induced by 5-fluorouracil","volume":"12","author":"Luwaert","year":"1991","unstructured":"Luwaert RJ, Descamps O, Majois F, Chaudron JM and Beauduin M. Coronary artery spasm induced by 5-fluorouracil. Eur Heart J 1991; 12: 468-470.","journal-title":"Eur Heart J"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1177\/107327480401100107","article-title":"5-fluorouracil-induced coronary vasospasm","volume":"11","author":"LK","year":"2004","unstructured":"Shoemaker LK, Arora U and Rocha Lima CM. 5-fluorouracil-induced coronary vasospasm. Cancer Control 2004; 11: 46-49.","journal-title":"Cancer Control"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"101300","DOI":"10.1016\/j.ijcha.2023.101300","article-title":"Impaired microvascular reactivity in patients treated with 5-fluorouracil chemotherapy regimens: potential role of endothelial dysfunction","volume":"49","author":"Hammond","year":"2023","unstructured":"Hammond ST, Baumfalk DR, Parr SK, Butenas ALE, Scheuermann BC, Turpin VG, Behnke BJ, Hashmi MH and Ade CJ. Impaired microvascular reactivity in patients treated with 5-fluorouracil chemotherapy regimens: potential role of endothelial dysfunction. Int J Cardiol Heart Vasc 2023; 49: 101300.","journal-title":"Int J Cardiol Heart Vasc"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1007\/s12032-009-9226-8","article-title":"5-fluorouracil induces arterial vasoconstrictions but does not increase angiotensin II levels","volume":"27","author":"Salepci","year":"2010","unstructured":"Salepci T, Seker M, Uyarel H, Gumus M, Bilici A, Ustaalioglu BB, Ozturk A, Sonmez B, Orcun A, Ozates M, Irmak R and Yaylaci M. 5-fluorouracil induces arterial vasoconstrictions but does not increase angiotensin II levels. Med Oncol 2010; 27: 416-420.","journal-title":"Med Oncol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1093\/annonc\/mdh150","article-title":"5-fluorouracil induces arterial vasocontractions","volume":"15","author":"Sudhoff","year":"2004","unstructured":"Sudhoff T, Enderle MD, Pahlke M, Petz C, Teschendorf C, Graeven U and Schmiegel W. 5-fluorouracil induces arterial vasocontractions. Ann Oncol 2004; 15: 661-664.","journal-title":"Ann Oncol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.2147\/CMAR.S223032","article-title":"Cardiotoxic profile and arterial stiffness of adjuvant chemotherapy for colorectal cancer","volume":"12","author":"Visvikis","year":"2020","unstructured":"Visvikis A, Kyvelou SM, Pietri P, Georgakopoulos C, Manousou K, Tousoulis D, Stefanadis C, Vlachopoulos C and Pektasides D. Cardiotoxic profile and arterial stiffness of adjuvant chemotherapy for colorectal cancer. Cancer Manag Res 2020; 12: 1175-1185.","journal-title":"Cancer Manag Res"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Focaccetti C, Bruno A, Magnani E, Bartolini D, Principi E, Dallaglio K, Bucci EO, Finzi G, Sessa F, Noonan DM and Albini A. Effects of 5-fluorouracil on morphology, cell cycle, proliferation, apoptosis, autophagy and ROS production in endothelial cells and cardiomyocytes. PLoS One 2015; 10: e0115686.","DOI":"10.1371\/journal.pone.0115686"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"14693","DOI":"10.1038\/s41598-020-71531-8","article-title":"Activated ROCK\/Akt\/eNOS and ET-1\/ERK pathways in 5-fluorouracil-induced cardiotoxicity: modulation by simvastatin","volume":"10","author":"Muhammad","year":"2020","unstructured":"Muhammad RN, Sallam N and El-Abhar HS. Activated ROCK\/Akt\/eNOS and ET-1\/ERK pathways in 5-fluorouracil-induced cardiotoxicity: modulation by simvastatin. Sci Rep 2020; 10: 14693.","journal-title":"Sci Rep"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1191\/0960327106ht628oa","article-title":"Cardiac lesions induced by 5-fluorouracil in the rabbit","volume":"25","author":"Tsibiribi","year":"2006","unstructured":"Tsibiribi P, Bui-Xuan C, Bui-Xuan B, Lombard-Bohas C, Duperret S, Belkhiria M, Tabib A, Maujean G, Descotes J and Timour Q. Cardiac lesions induced by 5-fluorouracil in the rabbit. Hum Exp Toxicol 2006; 25: 305-309.","journal-title":"Hum Exp Toxicol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"6666","DOI":"10.12659\/MSM.910537","article-title":"Mitochondrial dynamics in rat heart induced by 5-fluorouracil","volume":"24","author":"Zhang","year":"2018","unstructured":"Zhang D and Ma J. Mitochondrial dynamics in rat heart induced by 5-fluorouracil. Med Sci Monit 2018; 24: 6666-6672.","journal-title":"Med Sci Monit"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"3713","DOI":"10.1111\/bph.13725","article-title":"5-fluorouracil causes endothelial cell senescence: potential protective role of glucagon-like peptide 1","volume":"174","author":"Altieri","year":"2017","unstructured":"Altieri P, Murialdo R, Barisione C, Lazzarini E, Garibaldi S, Fabbi P, Ruggeri C, Borile S, Carbone F, Armirotti A, Canepa M, Ballestrero A, Brunelli C, Montecucco F, Ameri P and Spallarossa P. 5-fluorouracil causes endothelial cell senescence: potential protective role of glucagon-like peptide 1. Br J Pharmacol 2017; 174: 3713-3726.","journal-title":"Br J Pharmacol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1093\/oxfordjournals.annonc.a010723","article-title":"An experimental study using endothelial cells in the culture","volume":"7","author":"Cwikiel","year":"1996","unstructured":"Cwikiel M, Eskilsson J, Albertsson M and Stavenow L. The influence of 5-fluorouracil and methotrexate on vascular endothelium. An experimental study using endothelial cells in the culture. Ann Oncol 1996; 7: 731-737.","journal-title":"Ann Oncol"},{"key":"ref23","unstructured":"Cwikiel M, Eskilsson J, Wieslander JB, Stjernquist U and Albertsson M. The appearance of endothelium in small arteries after treatment with 5-fluorouracil. An electron microscopic study of late effects in rabbits. Scanning Microsc 1996; 10: 805-818; discussion 819."},{"key":"ref24","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.taap.2013.03.011","article-title":"Breast cancer drugs dampen vascular functions by interfering with nitric oxide signaling in endothelium","volume":"269","author":"Gajalakshmi","year":"2013","unstructured":"Gajalakshmi P, Priya MK, Pradeep T, Behera J, Muthumani K, Madhuwanti S, Saran U and Chatterjee S. Breast cancer drugs dampen vascular functions by interfering with nitric oxide signaling in endothelium. Toxicol Appl Pharmacol 2013; 269: 121-131.","journal-title":"Toxicol Appl Pharmacol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/sca.4950230101","article-title":"Antithrombotic treatment in protection against thrombogenic effects of 5-fluorouracil on vascular endothelium: a scanning microscopy evaluation","volume":"23","author":"Kinhult","year":"2001","unstructured":"Kinhult S, Albertsson M, Eskilsson J and Cwikiel M. Antithrombotic treatment in protection against thrombogenic effects of 5-fluorouracil on vascular endothelium: a scanning microscopy evaluation. Scanning 2001; 23: 1-8.","journal-title":"Scanning"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1080\/02841860310004409","article-title":"Effects of probucol on endothelial damage by 5-fluorouracil","volume":"42","author":"Kinhult","year":"2003","unstructured":"Kinhult S, Albertsson M, Eskilsson J and Cwikiel M. Effects of probucol on endothelial damage by 5-fluorouracil. Acta Oncol 2003; 42: 304-308.","journal-title":"Acta Oncol"},{"key":"ref27","unstructured":"Mosseri M, Fingert HJ, Varticovski L, Chokshi S and Isner JM. In vitro evidence that myocardial ischemia resulting from 5-fluorouracil chemotherapy is due to protein kinase C-mediated vasoconstriction of vascular smooth muscle. Cancer Res 1993; 53: 3028-3033."},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.3892\/etm.2021.10886","article-title":"Dynamic observation of 5-fluorouracil-induced myocardial injury and mitochondrial autophagy in aging rats","volume":"22","author":"Li","year":"2021","unstructured":"Li Y, Zhang Y, Zhou X, Lei X, Li X and Wei L. Dynamic observation of 5-fluorouracil-induced myocardial injury and mitochondrial autophagy in aging rats. Exp Ther Med 2021; 22: 1451.","journal-title":"Exp Ther Med"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/sj.bjc.6600467","article-title":"A ‘modified de Gramont’ regimen of fluorouracil, alone and with oxaliplatin, for advanced colorectal cancer","volume":"87","author":"Cheeseman","year":"2002","unstructured":"Cheeseman SL, Joel SP, Chester JD, Wilson G, Dent JT, Richards FJ and Seymour MT. A ‘modified de Gramont’ regimen of fluorouracil, alone and with oxaliplatin, for advanced colorectal cancer. Br J Cancer 2002; 87: 393-399.","journal-title":"Br J Cancer"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1056\/NEJMoa1011923","article-title":"FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer","volume":"364","author":"Conroy","year":"2011","unstructured":"Conroy T, Desseigne F, Ychou M, Bouche O, Guimbaud R, Becouarn Y, Adenis A, Raoul JL, Gourgou-Bourgade S, de la Fouchardiere C, Bennouna J, Bachet JB, Khemissa-Akouz F, Pere-Verge D, Delbaldo C, Assenat E, Chauffert B, Michel P, Montoto-Grillot C and Ducreux M; Groupe Tumeurs Digestives of Unicancer; PRODIGE Intergroup. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med 2011; 364: 1817-1825.","journal-title":"N Engl J Med"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.clcc.2013.04.006","article-title":"FOLFIRI-bevacizumab as first-line chemotherapy in 3500 patients with advanced colorectal cancer: a pooled analysis of 29 published trials","volume":"12","author":"Petrelli","year":"2013","unstructured":"Petrelli F, Borgonovo K, Cabiddu M, Ghilardi M, Lonati V, Maspero F, Sauta MG, Beretta GD and Barni S. FOLFIRI-bevacizumab as first-line chemotherapy in 3500 patients with advanced colorectal cancer: a pooled analysis of 29 published trials. Clin Colorectal Cancer 2013; 12: 145-151.","journal-title":"Clin Colorectal Cancer"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s00432-007-0250-9","article-title":"Cardiotoxicity of fluoropyrimidines in different schedules of administration: a prospective study","volume":"134","author":"Kosmas","year":"2008","unstructured":"Kosmas C, Kallistratos MS, Kopterides P, Syrios J, Skopelitis H, Mylonakis N, Karabelis A and Tsavaris N. Cardiotoxicity of fluoropyrimidines in different schedules of administration: a prospective study. J Cancer Res Clin Oncol 2008; 134: 75-82.","journal-title":"J Cancer Res Clin Oncol"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1517\/14740330902733961","article-title":"Fluoropyrimidine-associated cardiotoxicity: revisited","volume":"8","author":"MW","year":"2009","unstructured":"Saif MW, Shah MM and Shah AR. Fluoropyrimidine-associated cardiotoxicity: revisited. Expert Opin Drug Saf 2009; 8: 191-202.","journal-title":"Expert Opin Drug Saf"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.3109\/02841869009091790","article-title":"Failure of preventing 5-fluorouracil cardiotoxicity by prophylactic treatment with verapamil","volume":"29","author":"Eskilsson","year":"1990","unstructured":"Eskilsson J and Albertsson M. Failure of preventing 5-fluorouracil cardiotoxicity by prophylactic treatment with verapamil. Acta Oncol 1990; 29: 1001-1003.","journal-title":"Acta Oncol"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1097\/00000441-198710000-00004","article-title":"5-fluorouracil cardiotoxicity: left ventricular dysfunction and effect of coronary vasodilators","volume":"294","author":"Patel","year":"1987","unstructured":"Patel B, Kloner RA, Ensley J, Al-Sarraf M, Kish J and Wynne J. 5-fluorouracil cardiotoxicity: left ventricular dysfunction and effect of coronary vasodilators. Am J Med Sci 1987; 294: 238-243.","journal-title":"Am J Med Sci"},{"key":"ref36","doi-asserted-by":"publisher","unstructured":"Zafar A, Drobni ZD, Lei M, Gongora CA, Quinaglia T, Lou UY, Mosarla R, Murphy SP, Jones-O’Connor M, Mahmood A, Hartmann S, Gilman HK, Weekes CD, Nipp R, Clark JR, Clark JW, Blaszkowsky LS, Tavares E and Neilan TG. The efficacy and safety of cardio-protective therapy in patients with 5-FU (Fluorouracil)-associated coronary vasospasm. PLoS One 2022; 17: e0265767.","DOI":"10.1371\/journal.pone.0265767"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/j.jacc.2022.07.004","article-title":"Exercise for primary and secondary prevention of cardiovascular disease: JACC focus seminar 1\/4","volume":"80","author":"Tucker","year":"2022","unstructured":"Tucker WJ, Fegers-Wustrow I, Halle M, Haykowsky MJ, Chung EH and Kovacic JC. Exercise for primary and secondary prevention of cardiovascular disease: JACC focus seminar 1\/4. J Am Coll Cardiol 2022; 80: 1091-1106.","journal-title":"J Am Coll Cardiol"},{"key":"ref38","doi-asserted-by":"publisher","unstructured":"Chicco AJ, Schneider CM and Hayward R. Voluntary exercise protects against acute doxorubicin cardiotoxicity in the isolated perfused rat heart. Am J Physiol Regul Integr Comp Physiol 2005; 289: R424-R431.","DOI":"10.1152\/ajpregu.00636.2004"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1097\/01.fjc.0000199682.43448.2d","article-title":"Exercise training attenuates acute doxorubicin-induced cardiac dysfunction","volume":"47","author":"AJ","year":"2006","unstructured":"Chicco AJ, Schneider CM and Hayward R. Exercise training attenuates acute doxorubicin-induced cardiac dysfunction. J Cardiovasc Pharmacol 2006; 47: 182-189.","journal-title":"J Cardiovasc Pharmacol"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1161\/CIRCRESAHA.123.323346","article-title":"Exercise inhibits doxorubicin-induced cardiotoxicity via regulating B cells","volume":"134","author":"Wang","year":"2024","unstructured":"Wang J, Liu S, Meng X, Zhao X, Wang T, Lei Z, Lehmann HI, Li G, Alcaide P, Bei Y and Xiao J. Exercise inhibits doxorubicin-induced cardiotoxicity via regulating B cells. Circ Res 2024; 134: 550-568.","journal-title":"Circ Res"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s12012-017-9412-4","article-title":"Exercise and doxorubicin treatment modulate cardiac mitochondrial quality control signaling","volume":"18","author":"Marques-Aleixo I","year":"2018","unstructured":"Marques-Aleixo I, Santos-Alves E, Torrella JR, Oliveira PJ, Magalhães J and Ascensão A. Exercise and doxorubicin treatment modulate cardiac mitochondrial quality control signaling. Cardiovasc Toxicol 2018; 18: 43-55.","journal-title":"Cardiovasc Toxicol"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1097\/MCA.0b013e32835cbef5","article-title":"Aerobic interval exercise training in the afternoon reduces attacks of coronary spastic angina in conjunction with improvement in endothelial function, oxidative stress, and inflammation","volume":"24","author":"Morikawa","year":"2013","unstructured":"Morikawa Y, Mizuno Y, Harada E, Katoh D, Kashiwagi Y, Morita S, Yoshimura M, Uemura S, Saito Y and Yasue H. Aerobic interval exercise training in the afternoon reduces attacks of coronary spastic angina in conjunction with improvement in endothelial function, oxidative stress, and inflammation. Coron Artery Dis 2013; 24: 177-182.","journal-title":"Coron Artery Dis"},{"key":"ref43","doi-asserted-by":"publisher","unstructured":"Thijssen DHJ, Uthman L, Somani Y and van Royen N. Short-term exercise-induced protection of cardiovascular function and health: why and how fast does the heart benefit from exercise? J Physiol 2022; 600: 1339-1355.","DOI":"10.1113\/JP282000"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1042\/CS20100254","article-title":"Acute exercise protects against calcium-induced cardiac mitochondrial permeability transition pore opening in doxorubicin-treated rats","volume":"120","author":"Ascensao","year":"2011","unstructured":"Ascensao A, Lumini-Oliveira J, Machado NG, Ferreira RM, Goncalves IO, Moreira AC, Marques F, Sardao VA, Oliveira PJ and Magalhaes J. Acute exercise protects against calcium-induced cardiac mitochondrial permeability transition pore opening in doxorubicin-treated rats. Clin Sci (Lond) 2011; 120: 37-49.","journal-title":"Clin Sci (Lond)"},{"key":"ref45","doi-asserted-by":"publisher","unstructured":"Kavazis AN, Smuder AJ, Min K, Tumer N and Powers SK. Short-term exercise training protects against doxorubicin-induced cardiac mitochondrial damage independent of HSP72. Am J Physiol Heart Circ Physiol 2010; 299: H1515-1524.","DOI":"10.1152\/ajpheart.00585.2010"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1152\/japplphysiol.00210.2014","article-title":"Effects of short-term endurance exercise training on acute doxorubicin-induced FoxO transcription in cardiac and skeletal muscle","volume":"117","author":"AN","year":"2014","unstructured":"Kavazis AN, Smuder AJ and Powers SK. Effects of short-term endurance exercise training on acute doxorubicin-induced FoxO transcription in cardiac and skeletal muscle. J Appl Physiol (1985) 2014; 117: 223-230.","journal-title":"J Appl Physiol (1985)"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1177\/1534735408322848","article-title":"Acute exercise protects against doxorubicin cardiotoxicity","volume":"7","author":"Wonders","year":"2008","unstructured":"Wonders KY, Hydock DS, Schneider CM and Hayward R. Acute exercise protects against doxorubicin cardiotoxicity. Integr Cancer Ther 2008; 7: 147-154.","journal-title":"Integr Cancer Ther"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1152\/japplphysiol.00829.2018","article-title":"Effects of prostate cancer and exercise training on left ventricular function and cardiac and skeletal muscle mass","volume":"126","author":"Baumfalk","year":"2019","unstructured":"Baumfalk DR, Opoku-Acheampong AB, Caldwell JT, Ade CJ, Copp SW, Musch TI and Behnke BJ. Effects of prostate cancer and exercise training on left ventricular function and cardiac and skeletal muscle mass. J Appl Physiol (1985) 2019; 126: 668-680.","journal-title":"J Appl Physiol (1985)"},{"key":"ref49","unstructured":"Esau PJ, Gittemeier EM, Opoku-Acheampong AB, Rollins KS, Baumfalk DR, Poole DC, Musch TI, Behnke BJ and Copp SW. Prostate cancer reduces endurance exercise capacity in association with reductions in cardiac and skeletal muscle mass in the rat. Am J Cancer Res 2017; 7: 2566-2576."},{"key":"ref50","doi-asserted-by":"publisher","first-page":"619622","DOI":"10.3389\/fonc.2020.619622","article-title":"Increased risk of cardiovascular death in breast cancer patients without chemotherapy or (and) radiotherapy: a large population-based study","volume":"10","author":"Guan","year":"2020","unstructured":"Guan T, Zhang H, Yang J, Lin W, Wang K, Su M, Peng W, Li Y, Lai Y and Liu C. Increased risk of cardiovascular death in breast cancer patients without chemotherapy or (and) radiotherapy: a large population-based study. Front Oncol 2020; 10: 619622.","journal-title":"Front Oncol"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1016\/j.ajpath.2024.06.008","article-title":"Cardiac atrophy, dysfunction, and metabolic impairments: a cancer-induced cardiomyopathy phenotype","volume":"194","author":"Ogilvie","year":"2024","unstructured":"Ogilvie LM, Delfinis LJ, Coyle-Asbil B, Vudatha V, Alshamali R, Garlisi B, Pereira M, Matuszewska K, Garibotti MC, Gandhi S, Brunt KR, Wood GA, Trevino JG, Perry CGR, Petrik J and Simpson JA. Cardiac atrophy, dysfunction, and metabolic impairments: a cancer-induced cardiomyopathy phenotype. Am J Pathol 2024; 194: 1823-1843.","journal-title":"Am J Pathol"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1152\/jappl.1979.47.6.1278","article-title":"Maximum oxygen consumption of rats and its changes with various experimental procedures","volume":"47","author":"Bedford","year":"1979","unstructured":"Bedford TG, Tipton CM, Wilson NC, Oppliger RA and Gisolfi CV. Maximum oxygen consumption of rats and its changes with various experimental procedures. J Appl Physiol Respir Environ Exerc Physiol 1979; 47: 1278-1283.","journal-title":"J Appl Physiol Respir Environ Exerc Physiol"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"27","DOI":"10.4103\/0976-0105.177703","article-title":"A simple practice guide for dose conversion between animals and human","volume":"7","author":"Nair","year":"2016","unstructured":"Nair AB and Jacob S. A simple practice guide for dose conversion between animals and human. J Basic Clin Pharm 2016; 7: 27-31.","journal-title":"J Basic Clin Pharm"},{"key":"ref54","doi-asserted-by":"publisher","unstructured":"Craig JC, Colburn TD, Caldwell JT, Hirai DM, Tabuchi A, Baumfalk DR, Behnke BJ, Ade CJ, Musch TI and Poole DC. Central and peripheral factors mechanistically linked to exercise intolerance in heart failure with reduced ejection fraction. Am J Physiol Heart Circ Physiol 2019; 317: H434-H444.","DOI":"10.1152\/ajpheart.00164.2019"},{"key":"ref55","doi-asserted-by":"publisher","unstructured":"Butenas ALE, Rollins KS, Williams AC, Parr SK, Hammond ST, Ade CJ, Hageman KS, Musch TI and Copp SW. Thromboxane A(2) receptors contribute to the exaggerated exercise pressor reflex in male rats with heart failure. Physiol Rep 2021; 9: e15052.","DOI":"10.14814\/phy2.15052"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"102784","DOI":"10.1016\/j.autneu.2021.102784","article-title":"Exaggerated sympathetic and cardiovascular responses to dynamic mechanoreflex activation in rats with heart failure: role of endoperoxide 4 and thromboxane A(2) receptors","volume":"232","author":"Butenas","year":"2021","unstructured":"Butenas ALE, Rollins KS, Williams AC, Parr SK, Hammond ST, Ade CJ, Hageman KS, Musch TI and Copp SW. Exaggerated sympathetic and cardiovascular responses to dynamic mechanoreflex activation in rats with heart failure: role of endoperoxide 4 and thromboxane A(2) receptors. Auton Neurosci 2021; 232: 102784.","journal-title":"Auton Neurosci"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1113\/EP088835","article-title":"No effect of endoperoxide 4 or thromboxane A(2) receptor blockade on static mechanoreflex activation in rats with heart failure","volume":"105","author":"Butenas","year":"2020","unstructured":"Butenas ALE, Rollins KS, Matney JE, Williams AC, Kleweno TE, Parr SK, Hammond ST, Ade CJ, Hageman KS, Musch TI and Copp SW. No effect of endoperoxide 4 or thromboxane A(2) receptor blockade on static mechanoreflex activation in rats with heart failure. Exp Physiol 2020; 105: 1840-1854.","journal-title":"Exp Physiol"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/0002-9149(76)90491-4","article-title":"Problems in echocardiographic volume determinations: echocardiographic-angiographic correlations in the presence of absence of asynergy","volume":"37","author":"Teichholz","year":"1976","unstructured":"Teichholz LE, Kreulen T, Herman MV and Gorlin R. Problems in echocardiographic volume determinations: echocardiographic-angiographic correlations in the presence of absence of asynergy. Am J Cardiol 1976; 37: 7-11.","journal-title":"Am J Cardiol"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"2588","DOI":"10.1093\/eurheartj\/ehl254","article-title":"Expert consensus document on arterial stiffness: methodological issues and clinical applications","volume":"27","author":"Laurent","year":"2006","unstructured":"Laurent S, Cockcroft J, Van Bortel L, Boutouyrie P, Giannattasio C, Hayoz D, Pannier B, Vlachopoulos C, Wilkinson I and Struijker-Boudier H; European Network for Non-invasive Investigation of Large Arteries. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 2006; 27: 2588-2605.","journal-title":"Eur Heart J"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"2598","DOI":"10.1152\/jappl.1993.74.5.2598","article-title":"Echocardiographic evaluation of size, function, and mass of normal and hypertrophied rat ventricles","volume":"74","author":"Pawlush","year":"1993","unstructured":"Pawlush DG, Moore RL, Musch TI and Davidson WR Jr. Echocardiographic evaluation of size, function, and mass of normal and hypertrophied rat ventricles. J Appl Physiol (1985) 1993; 74: 2598-2605.","journal-title":"J Appl Physiol (1985)"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1001\/jama.1962.03050300015003","article-title":"Five years clinical experience with 5-fluorouracil","volume":"181","author":"FJ","year":"1962","unstructured":"Ansfield FJ, Schroeder JM and Curreri AR. Five years clinical experience with 5-fluorouracil. JAMA 1962; 181: 295-299.","journal-title":"JAMA"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.clcc.2014.11.002","article-title":"A review of the evolution of systemic chemotherapy in the management of colorectal cancer","volume":"14","author":"Gustavsson","year":"2015","unstructured":"Gustavsson B, Carlsson G, Machover D, Petrelli N, Roth A, Schmoll HJ, Tveit KM and Gibson F. A review of the evolution of systemic chemotherapy in the management of colorectal cancer. Clin Colorectal Cancer 2015; 14: 1-10.","journal-title":"Clin Colorectal Cancer"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1093\/annonc\/mdu055","article-title":"Effort myocardial ischemia during chemotherapy with 5-fluorouracil: an underestimated risk","volume":"25","author":"Lestuzzi","year":"2014","unstructured":"Lestuzzi C, Vaccher E, Talamini R, Lleshi A, Meneguzzo N, Viel E, Scalone S, Tartuferi L, Buonadonna A, Ejiofor L and Schmoll HJ. Effort myocardial ischemia during chemotherapy with 5-fluorouracil: an underestimated risk. Ann Oncol 2014; 25: 1059-1064.","journal-title":"Ann Oncol"},{"key":"ref64","doi-asserted-by":"publisher","unstructured":"Lestuzzi C, Tartuferi L, Viel E, Buonadonna A, Vaccher E and Berretta M. Fluoropyrimidine-associated cardiotoxicity: probably not so rare as it seems. Oncologist 2020; 25: e1254.","DOI":"10.1634\/theoncologist.2020-0053"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/2050-6511-15-47","article-title":"A systematic review of the pathophysiology of 5-fluorouracil-induced cardiotoxicity","volume":"15","author":"Polk","year":"2014","unstructured":"Polk A, Vistisen K, Vaage-Nilsen M and Nielsen DL. A systematic review of the pathophysiology of 5-fluorouracil-induced cardiotoxicity. BMC Pharmacol Toxicol 2014; 15: 47.","journal-title":"BMC Pharmacol Toxicol"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/S0021-5198(19)52945-6","article-title":"Cardiotoxic effects of 5-fluorouracil in the guinea pig","volume":"30","author":"Matsubara","year":"1980","unstructured":"Matsubara I, Kamiya J and Imai S. Cardiotoxic effects of 5-fluorouracil in the guinea pig. Jpn J Pharmacol 1980; 30: 871-879.","journal-title":"Jpn J Pharmacol"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"8661","DOI":"10.1038\/s41598-022-12735-y","article-title":"The effect of propolis on 5-fluorouracil-induced cardiac toxicity in rats","volume":"12","author":"Barary","year":"2022","unstructured":"Barary M, Hosseinzadeh R, Kazemi S, Liang JJ, Mansoori R, Sio TT, Hosseini M and Moghadamnia AA. The effect of propolis on 5-fluorouracil-induced cardiac toxicity in rats. Sci Rep 2022; 12: 8661.","journal-title":"Sci Rep"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1080\/009841000156709","article-title":"Reduced antioxidant defense capacity in myocardial tissue from guinea pigs treated with 5-fluorouracil","volume":"59","author":"Durak","year":"2000","unstructured":"Durak I, Karaayvaz M, Kavutcu M, Cimen MY, Kacmaz M, Buyukkocak S and Ozturk HS. Reduced antioxidant defense capacity in myocardial tissue from guinea pigs treated with 5-fluorouracil. J Toxicol Environ Health A 2000; 59: 585-589.","journal-title":"J Toxicol Environ Health A"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1007\/s00384-021-03888-9","article-title":"The comparison of FOLFOX regimens with different doses of 5-FU for the adjuvant treatment of colorectal cancer: a multicenter study","volume":"36","author":"Akdeniz","year":"2021","unstructured":"Akdeniz N, Kaplan MA, Uncu D, Inanc M, Kaya S, Dane F, Kucukoner M, Demirci A, Bilici M, Durnali AG, Koral L, Sendur MAN, Erol C, Turkmen E, Olmez OF, Acikgoz O, Lacin S, Sahinli H, Urakci Z and Isikdogan A. The comparison of FOLFOX regimens with different doses of 5-FU for the adjuvant treatment of colorectal cancer: a multicenter study. Int J Colorectal Dis 2021; 36: 1311-1319.","journal-title":"Int J Colorectal Dis"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s13691-021-00526-7","article-title":"Should we still be using bolus 5-FU prior to infusional regimens in gastrointestinal cancers? A practical review","volume":"11","author":"Amorim","year":"2022","unstructured":"Amorim LC and Peixoto RD. Should we still be using bolus 5-FU prior to infusional regimens in gastrointestinal cancers? A practical review. Int Cancer Conf J 2022; 11: 2-5.","journal-title":"Int Cancer Conf J"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1200\/JCO.1997.15.2.808","article-title":"Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: a French intergroup study","volume":"15","author":"de Gramont","year":"1997","unstructured":"de Gramont A, Bosset JF, Milan C, Rougier P, Bouche O, Etienne PL, Morvan F, Louvet C, Guillot T, Francois E and Bedenne L. Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: a French intergroup study. J Clin Oncol 1997; 15: 808-815.","journal-title":"J Clin Oncol"},{"key":"ref72","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s12012-020-09562-w","article-title":"Various manifestations of 5-fluorouracil cardiotoxicity: a multicenter case series and review of literature","volume":"20","author":"Allison","year":"2020","unstructured":"Allison JD, Tanavin T, Yang Y, Birnbaum G and Khalid U. Various manifestations of 5-fluorouracil cardiotoxicity: a multicenter case series and review of literature. Cardiovasc Toxicol 2020; 20: 437-442.","journal-title":"Cardiovasc Toxicol"},{"key":"ref73","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/0002-9343(88)90615-8","article-title":"Profound, yet reversible, heart failure secondary to 5-fluorouracil","volume":"85","author":"Chaudary","year":"1988","unstructured":"Chaudary S, Song SY and Jaski BE. Profound, yet reversible, heart failure secondary to 5-fluorouracil. Am J Med 1988; 85: 454-456.","journal-title":"Am J Med"},{"key":"ref74","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1152\/jappl.1992.73.1.143","article-title":"A time-course study of the effects of pentobarbital, fentanyl, and morphine chloralose on myocardial mechanics","volume":"73","author":"Lang","year":"1992","unstructured":"Lang RM, Marcus RH, Neumann A, Janzen D, Hansen D, Fujii AM and Borow KM. A time-course study of the effects of pentobarbital, fentanyl, and morphine chloralose on myocardial mechanics. J Appl Physiol (1985) 1992; 73: 143-150.","journal-title":"J Appl Physiol (1985)"},{"key":"ref75","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1152\/japplphysiol.00005.2018","article-title":"Vascular and autonomic changes in adult cancer patients receiving anticancer chemotherapy","volume":"125","author":"Frye","year":"2018","unstructured":"Frye JN, Sutterfield SL, Caldwell JT, Behnke BJ, Copp SW, Banister HR and Ade CJ. Vascular and autonomic changes in adult cancer patients receiving anticancer chemotherapy. J Appl Physiol (1985) 2018; 125: 198-204.","journal-title":"J Appl Physiol (1985)"},{"key":"ref76","doi-asserted-by":"publisher","unstructured":"Parr SK, Liang J, Schadler KL, Gilchrist SC, Steele CC and Ade CJ. Anticancer therapy-related increases in arterial stiffness: a systematic review and meta-analysis. J Am Heart Assoc 2020; 9: e015598.","DOI":"10.1161\/JAHA.119.015598"},{"key":"ref77","doi-asserted-by":"publisher","first-page":"100085","DOI":"10.1016\/j.ijchy.2021.100085","article-title":"Arterial stiffness is associated with cardiovascular and cancer mortality in cancer patients: insight from NHANESIII","volume":"9","author":"Parr","year":"2021","unstructured":"Parr SK, Steele CC, Hammond ST, Turpin VRG and Ade CJ. Arterial stiffness is associated with cardiovascular and cancer mortality in cancer patients: insight from NHANESIII. Int J Cardiol Hypertens 2021; 9: 100085.","journal-title":"Int J Cardiol Hypertens"},{"key":"ref78","doi-asserted-by":"publisher","unstructured":"Groehs RV, Negrao MV, Hajjar LA, Jordao CP, Carvalho BP, Toschi-Dias E, Andrade AC, Hodas FP, Alves MJNN, Sarmento AO, Testa L, Hoff PMG, Negrao CE and Filho RK. Adjuvant treatment with 5-fluorouracil and oxaliplatin does not influence cardiac function, neurovascular control, and physical capacity in patients with colon cancer. Oncologist 2021; 26: e907.","DOI":"10.1002\/onco.13732"},{"key":"ref79","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1016\/j.molmed.2019.08.006","article-title":"The vicious cycle of arterial stiffness and arterial media calcification","volume":"25","author":"den Bergh G","year":"2019","unstructured":"Van den Bergh G, Opdebeeck B, D’Haese PC and Verhulst A. The vicious cycle of arterial stiffness and arterial media calcification. Trends Mol Med 2019; 25: 1133-1146.","journal-title":"Trends Mol Med"},{"key":"ref80","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/S0008-6363(01)00299-1","article-title":"Nitric oxide synthase inhibition increases aortic stiffness measured by pulse wave velocity in rats","volume":"51","author":"Fitch","year":"2001","unstructured":"Fitch RM, Vergona R, Sullivan ME and Wang YX. Nitric oxide synthase inhibition increases aortic stiffness measured by pulse wave velocity in rats. Cardiovasc Res 2001; 51: 351-358.","journal-title":"Cardiovasc Res"},{"key":"ref81","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1249\/01.MSS.0000117130.91142.38","article-title":"Training enhances vascular relaxation after chemotherapy-induced vasoconstriction","volume":"36","author":"Hayward","year":"2004","unstructured":"Hayward R, Ruangthai R, Schneider CM, Hyslop RM, Strange R and Westerlind KC. Training enhances vascular relaxation after chemotherapy-induced vasoconstriction. Med Sci Sports Exerc 2004; 36: 428-434.","journal-title":"Med Sci Sports Exerc"},{"key":"ref82","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.ijcard.2017.07.037","article-title":"Protective effects of acute exercise prior to doxorubicin on cardiac function of breast cancer patients: a proof-of-concept RCT","volume":"245","author":"Kirkham","year":"2017","unstructured":"Kirkham AA, Shave RE, Bland KA, Bovard JM, Eves ND, Gelmon KA, McKenzie DC, Virani SA, Stohr EJ, Warburton DER and Campbell KL. Protective effects of acute exercise prior to doxorubicin on cardiac function of breast cancer patients: a proof-of-concept RCT. Int J Cardiol 2017; 245: 263-270.","journal-title":"Int J Cardiol"},{"key":"ref83","doi-asserted-by":"publisher","first-page":"5337","DOI":"10.1007\/s11357-025-01648-z","article-title":"Treatment delay significantly increases mortality in colorectal cancer: a meta-analysis","volume":"47","author":"Ungvari","year":"2025","unstructured":"Ungvari Z, Fekete M, Fekete JT, Lehoczki A, Buda A, Munkácsy G, Varga P, Ungvari A and Győrffy B. Treatment delay significantly increases mortality in colorectal cancer: a meta-analysis. Geroscience 2025; 47: 5337-5353.","journal-title":"Geroscience"},{"key":"ref84","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1097\/DCR.0b013e3182a857eb","article-title":"Postoperative complications in patients with rectal cancer are associated with delays in chemotherapy that lead to worse disease-free and overall survival","volume":"56","author":"Tevis","year":"2013","unstructured":"Tevis SE, Kohlnhofer BM, Stringfield S, Foley EF, Harms BA, Heise CP and Kennedy GD. Postoperative complications in patients with rectal cancer are associated with delays in chemotherapy that lead to worse disease-free and overall survival. Dis Colon Rectum 2013; 56: 1339-1348.","journal-title":"Dis Colon Rectum"},{"key":"ref85","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.jaccao.2021.11.001","article-title":"Risk for myocardial infarction following 5-fluorouracil treatment in patients with gastrointestinal cancer: a nationwide registry-based study","volume":"3","author":"JWD","year":"2021","unstructured":"Shanmuganathan JWD, Kragholm K, Tayal B, Polcwiartek C, Poulsen LØ, El-Galaly TC, Fosbøl EL, D’Souza M, Gislason G, Køber L, Schou M, Nielsen D, Søgaard P, Torp-Pedersen CT, Mamas MA and Freeman P. Risk for myocardial infarction following 5-fluorouracil treatment in patients with gastrointestinal cancer: a nationwide registry-based study. JACC CardioOncol 2021; 3: 725-733.","journal-title":"JACC CardioOncol"},{"key":"ref86","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1056\/NEJMoa2502760","article-title":"Structured exercise after adjuvant chemotherapy for colon cancer","volume":"393","author":"KS","year":"2025","unstructured":"Courneya KS, Vardy JL, O’Callaghan CJ, Gill S, Friedenreich CM, Wong RKS, Dhillon HM, Coyle V, Chua NS, Jonker DJ, Beale PJ, Haider K, Tang PA, Bonaventura T, Wong R, Lim HJ, Burge ME, Hubay S, Sanatani M, Campbell KL, Arthuso FZ, Turner J, Meyer RM, Brundage M, O’Brien P, Tu D and Booth CM; CHALLENGE Investigators. Structured exercise after adjuvant chemotherapy for colon cancer. N Engl J Med 2025; 393: 13-25.","journal-title":"N Engl J Med"},{"key":"ref87","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s00395-006-0627-y","article-title":"Effects of anesthesia on echocardiographic assessment of left ventricular structure and function in rats","volume":"102","author":"Stein","year":"2007","unstructured":"Stein AB, Tiwari S, Thomas P, Hunt G, Levent C, Stoddard MF, Tang XL, Bolli R and Dawn B. Effects of anesthesia on echocardiographic assessment of left ventricular structure and function in rats. Basic Res Cardiol 2007; 102: 28-41.","journal-title":"Basic Res Cardiol"},{"key":"ref88","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1161\/CIRCULATIONAHA.107.720953","article-title":"Prevalence of angina in women versus men: a systematic review and meta-analysis of international variations across 31 countries","volume":"117","author":"Hemingway","year":"2008","unstructured":"Hemingway H, Langenberg C, Damant J, Frost C, Pyörälä K and Barrett-Connor E. Prevalence of angina in women versus men: a systematic review and meta-analysis of international variations across 31 countries. Circulation 2008; 117: 1526-1536.","journal-title":"Circulation"},{"key":"ref89","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1161\/CIRCRESAHA.121.319902","article-title":"Sex differences in myocardial and vascular aging","volume":"130","author":"Ji","year":"2022","unstructured":"Ji H, Kwan AC, Chen MT, Ouyang D, Ebinger JE, Bell SP, Niiranen TJ, Bello NA and Cheng S. Sex differences in myocardial and vascular aging. Circ Res 2022; 130: 566-577.","journal-title":"Circ Res"},{"key":"ref90","doi-asserted-by":"publisher","unstructured":"El Khoudary SR, Aggarwal B, Beckie TM, Hodis HN, Johnson AE, Langer RD, Limacher MC, Manson JE, Stefanick ML and Allison MA; American Heart Association Prevention Science Committee of the Council on Epidemiology and Prevention; and Council on Cardiovascular and Stroke Nursing. Menopause transition and cardiovascular disease risk: implications for timing of early prevention: a scientific statement from the american heart association. Circulation 2020; 142: e506-e532.","DOI":"10.1161\/CIR.0000000000000912"},{"key":"ref91","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1113\/EP088548","article-title":"Physiological sex differences affect the integrative response to exercise: acute and chronic implications","volume":"105","author":"Ansdell","year":"2020","unstructured":"Ansdell P, Thomas K, Hicks KM, Hunter SK, Howatson G and Goodall S. Physiological sex differences affect the integrative response to exercise: acute and chronic implications. Exp Physiol 2020; 105: 2007-2021.","journal-title":"Exp Physiol"},{"key":"ref92","doi-asserted-by":"publisher","first-page":"1149633","DOI":"10.3389\/fcvm.2023.1149633","article-title":"The impact of tumor characteristics on cardiovascular disease death in breast cancer patients with CT or RT: a population-based study","volume":"10","author":"Chi","year":"2023","unstructured":"Chi K, Luo Z, Zhao H, Li Y, Liang Y, Xiao Z, He Y, Zhang H, Ma Z, Zeng L, Zhou R, Feng M, Li W, Rao H and Yi M. The impact of tumor characteristics on cardiovascular disease death in breast cancer patients with CT or RT: a population-based study. Front Cardiovasc Med 2023; 10: 1149633.","journal-title":"Front Cardiovasc Med"},{"key":"ref93","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.clcc.2018.10.006","article-title":"5-fluorouracil-related cardiotoxicity; findings from five randomized studies of 5-fluorouracil-based regimens in metastatic colorectal cancer","volume":"18","author":"Abdel-Rahman","year":"2019","unstructured":"Abdel-Rahman O. 5-fluorouracil-related cardiotoxicity; findings from five randomized studies of 5-fluorouracil-based regimens in metastatic colorectal cancer. Clin Colorectal Cancer 2019; 18: 58-63.","journal-title":"Clin Colorectal Cancer"}],"container-title":["American Journal of Cancer Research"],"original-title":[],"link":[{"URL":"https:\/\/e-century.us\/files\/ajcr\/15\/9\/ajcr0166748.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T07:10:29Z","timestamp":1768893029000},"score":1,"resource":{"primary":{"URL":"https:\/\/e-century.us\/files\/ajcr\/15\/9\/ajcr0166748.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":94,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.62347\/ucjb2516","relation":{},"ISSN":["2156-6976"],"issn-type":[{"value":"2156-6976","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]}}}